PO.MCB08.04 · 分子与细胞生物学
在全器官尺度上通过多平台空间图谱构建膀胱癌从区域效应演化的模型
Modeling of bladder cancer evolution from field effects by multi-platform spatial mapping on the whole-organ scale
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
引言:除非在整个器官的地理分布背景下加以分析,否则无法理解驱动黏膜区域效应向浸润性癌演化的机制。膀胱癌是此类研究的理想模型疾病,因为它累及一个解剖结构简单的器官,从而允许在全器官尺度上对受累黏膜进行多平台分析。
方法:我们对九例患浸润性膀胱癌的膀胱切除标本进行了全面的多平台分析,包括433份黏膜组织样本,采用bulk全外显子组和mRNA测序、全基因组拷贝数变异和甲基化谱分析,并辅以蛋白质组学、代谢组学及单细胞测序空间图谱。多平台谱分析的数据在地理上被标注到显微镜下正常的尿路上皮(NU)和低级别尿路上皮内瘤变(LGIN;n=243)、高级别尿路上皮内瘤变(HGIN;n=90)以及浸润性尿路上皮癌(UC;n=100)。
结果:我们在每例膀胱切除标本中鉴定出约16000个非沉默突变。在两张图谱中检测到具有约48000和约57000个突变的超突变表型。突变分析依据变异等位基因频率和地理分布鉴定出三类突变,分别称为alpha、beta和ϒ。采用一个纳入细胞迁移(迁入)和生长(分支)的简约时间连续Markov模型进行时间建模,结果显示膀胱癌发生约需三十年,可分为静止期和进展期。低选择的alpha突变为私有突变且最为频繁。它们在30年间持续发展,主要发生在癌发生的静止期。beta突变在区域内克隆性扩增,标志着癌发生进展期的到来,该期持续五年。ϒ突变是进展期的最终驱动因素,在最终进展为浸润性膀胱癌前2-3年出现。突变图景在尿路上皮分化严重失调及伴T细胞耗竭的免疫浸润增加的背景下形成。蛋白质组学和代谢组学变化涉及糖脂能量代谢的广泛紊乱,伴线粒体氧化磷酸化下调。
结论:线粒体能量代谢失调趋向于无氧糖酵解和氧化磷酸化并呈现Warburg表型,成为驱动黏膜区域效应向浸润性癌进展的主导机制。
查看英文原文 English abstract
Introduction: Understanding the mechanisms driving evolution of the mucosal field effects to invasive cancer is not possible unless they are analyzed in the context of their geographic distribution in the entire organ. Bladder cancer is an ideal model disease for such studies as it effects an anatomically simple organ permitting the multi-platform analysis of the affected mucosa on the scale of whole organ.
Methods: We performed comprehensive multi-platform analyses on nine cystectomies with invasive bladder cancer comprising of 433 mucosal tissue samples analyzed by bulk whole-exome and mRNA sequencing, genome-wide copy number variation and methylation profiling complemented with proteomics, metabolomic and single cell sequencing spatial mapping. The data from multi-platform profiling were geographically annotated to microscopically normal urothelium (NU) and low-grade intraurothelial neoplasia (LGIN; n=243), high-grade intraurothelial neoplasia (HGIN; n=90), and invasive urothelial carcinoma (UC; n=100).
Results: We identified ~16000 non-silent mutations per cystectomy. In two maps the hypermutator phenotypes with ~48000 and ~57000 mutations were detected. The mutational analysis identified three types of mutations based on the variant allele frequency and geographic distribution referred to as alpha, beta, and ϒ. Time modeling by a parsimonious time-continuous Markov model incorporating cell migration (immigration) and growth (branching) revealed that bladder carcinogenesis takes approximately three decades and can be divided into dormant and progressive phases. Low selection alpha mutations were private and most frequent. They continuously developed over 30 years primarily in the dormant phase of carcinogenesis. beta mutations clonally expanded regionally and signified the advent of progressive phase of carcinogenesis which lasted five years. ϒ mutations were the ultimate drivers of the progressive phase and emerged 2-3 years before the final progression to invasive bladder cancer. The mutational landscape developed on the background of severely dysregulated urothelial differentiation and increased immune infiltration with T-cell exhaustion. The proteomic and metabolomic changes involved a wide-spread disorganization of glycolipid energy metabolism with downregulation of mitochondrial oxidative phosphorylation.
Conclusion: Dysregulated mitochondrial energy metabolism converging on anerobic glycolysis and oxidative phosphorylation with Warburg phenotype emerged as the leading mechanism driving the progression of mucosal field effects to invasive cancer.
利益披露 Disclosure
B. A. Czerniak, None..
S. Lee, None..
K. N. Dinh, None..
H. Chen, None..
Y. Wang, None..
J. Chen, None..
J. G. Lee, None..
S. Jung, None..
N. Putluri, None..
N. Navai, None..
D. McConkey, None..
C. C. Guo, None..
P. Wei, None..
M. Kimmel, None.